Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping combined with genome sequence analysis
Arnaud N’GuessaniD, Senthilkumar KailasamiD, Fatima MostefaiiD, Raphaël PoujoliD, Jean‐Christophe GrenieriD, Paola ContiniiD, Raffaele De PalmaiD, Carsten Haber, Volker StadleriD, Guillaume BourqueiD, Julie HussiniD, B. Jesse ShapiroiD, Jörg H. Fritz, Ciriaco A. PiccirilloiD
Abstract
A deeper understanding of the molecular determinants that drive humoral responses to coronaviruses, and in particular severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is critical for improving and developing diagnostics, therapies and vaccines. Moreover, viral mutations can change key antigens in a manner that alters the ability of the immune system to detect and clear infections. In this study, we exploit a deep serological profiling strategy coupled with an integrated, computational framework for the analysis of SARS-CoV-2 humoral immune responses of asymptomatic or recovered COVID-19-positive patients relative to COVID-19-negative patients. We made use of a novel high-density peptide array (HDPA) spanning the entire proteomes of SARS-CoV-2 and endemic human coronaviruses to rapidly identify B cell epitopes recognized by distinct antibody isotypes in patients blood sera. Using our integrated computational pipeline, we then evaluated the fine immunological properties of detected SARS-CoV-2 epitopes and relate them to their evolutionary and structural properties. While some epitopes are common across all CoVs, others are private to specific hCoVs. We also highlight the existence of hotspots of pre-existing immunity and identify a subset of cross-reactive epitopes that contributes to increasing the overall humoral immune response to SARS-CoV-2. Using a public dataset of over 38,000 viral genomes from the early phase of the pandemic, capturing both inter- and within-host genetic viral diversity, we determined the evolutionary profile of epitopes and the differences across proteins, waves and SARS-CoV-2 variants, which have important implications for genomic surveillance and vaccine design. Lastly, we show that mutations in Spike and Nucleocapsid epitopes are under stronger selection between than within patients, suggesting that most of the selective pressure for immune evasion occurs upon transmission between hosts.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antigenic variation of SARS-CoV-2 in response to immune pressure
D. Forni, R. Cagliani, … M. Sironi·bioRxiv·Jul 15, 2020
- Antigenic evolution on global scale reveals potential natural selection of SARS-CoV-2 by pre-existing cross-reactive T cell immunity
Chengdong Zhang, Xuanxuan Jin, … Tianyi Qiu·Frontiers in MicrobiologyPeer-reviewed·May 18, 2021
- Bioinformatic analysis of B and T cell epitopes from SARS-CoV-2 Spike, Membrane and Nucleocapsid proteins as a strategy to assess possible cross-reactivity between emerging variants, including Omicron, and other human coronaviruses
Diana Laura Pacheco-Olvera, Stephanie Saint Remy-Hernández, … Constantino III Roberto López-Macías·bioRxiv·Feb 16, 2022
- Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with an endemic human CoV
J. T. Ladner, S. N. Henson, … J. A. Altin·bioRxiv·Jul 27, 2020
- High-Throughput, Single-Copy Sequencing Reveals SARS-CoV-2 Spike Variants Coincident with Mounting Humoral Immunity during Acute COVID-19
S. H. Ko, E. Bayat Mokhtari, … E. A. Boritz·bioRxiv·Feb 21, 2021
- Epitope profiling reveals binding signatures of SARS-CoV-2 immune response and cross-reactivity with endemic HCoVs
C. I. Stoddard, J. Galloway, … Julie Overbaugh·bioRxiv·Oct 29, 2020